These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 37042596)
21. (N-NITROSO) PROPAFENONE INDUCED ADVANCED NODULAR MELANOMA-FIRST REPORTED CASE IN THE WORLD LITERATURE: THE INEXTRICABLE LINKS BETWEEN THE PHOTOCARCINOGENESIS, DRUG RELATED NITROSOGENESIS AND PHARMACO-ONCOGENESIS. Tchernev G Georgian Med News; 2024 Feb; (347):34-37. PubMed ID: 38609110 [TBL] [Abstract][Full Text] [Related]
22. Critical Analysis of Drug Product Recalls due to Nitrosamine Impurities. Bharate SS J Med Chem; 2021 Mar; 64(6):2923-2936. PubMed ID: 33706513 [TBL] [Abstract][Full Text] [Related]
23. Presence of nitrosamine impurities in medicinal products. Sedlo I; Kolonić T; Tomić S Arh Hig Rada Toksikol; 2021 Mar; 72(1):1-5. PubMed ID: 33787187 [TBL] [Abstract][Full Text] [Related]
24. Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices. Manchuri KM; Shaik MA; Gopireddy VSR; Naziya Sultana ; Gogineni S Chem Res Toxicol; 2024 Sep; 37(9):1456-1483. PubMed ID: 39158368 [TBL] [Abstract][Full Text] [Related]
25. MUSTARDE ROTATION FLAP AS ADEQUATE OPTION FOR HIGH-RISK BCC NEAR THE LOWER EYE LID: THE ADDITIONAL INTAKE OF N-NITROSO-FOLIC-ACID AND N-NITROSO-RIVOROXABAN AS COFACTORS/TRIGGERS OF THE METABOLIC REPROGRAMMING OF THE FUTURE CANCER CELL. Tchernev G; Ivanov L Georgian Med News; 2024 Jun; (351):131-137. PubMed ID: 39230235 [TBL] [Abstract][Full Text] [Related]
27. DRUG RELATED NITROSOGENESIS, PHOTOCARCINOGENESIS AND ONCOPHARMACOGENESIS OF NODULAR MELANOMA: A CASE RELATED ANALYSIS CONCERNING THE POLYCONTAMINATION OF THE POLYMEDICATION WITH VALSARTAN/HYDROCHLOROTHIAZIDE AND BISOPROLOL. Tchernev G; Broshtilova V; Ivanov L; Alexandrov A; Smilov N; Kordeva S Georgian Med News; 2024 Feb; (347):24-27. PubMed ID: 38609108 [TBL] [Abstract][Full Text] [Related]
28. A GC-MS/MS Method for Trace Level Quantification of Six Nitrosamine Impurities (NDMA, NDEA, NEIPA, NDIPA, NDPA, and NDBA) in Commercially Used Organic Solvents: Dichloromethane, Ethyl Acetate, Toluene, and O-xylene. Kosuri ER; Bhanti M; Jaywant MA; Han M; Wang X; Obeng M J Pharm Sci; 2023 May; 112(5):1225-1230. PubMed ID: 36462706 [TBL] [Abstract][Full Text] [Related]
29. Nitrosamine Contamination in Pharmaceuticals: Threat, Impact, and Control. Tuesuwan B; Vongsutilers V J Pharm Sci; 2021 Sep; 110(9):3118-3128. PubMed ID: 33989680 [TBL] [Abstract][Full Text] [Related]
30. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
31. MULTIPLE KERATINOCYTIC CANCERS AFTER ENALAPRIL/LOSARTAN INTAKE: POTENTIAL LINKS TO DRUG MEDIATED NITROSOGENESIS/CARCINOGENESIS: MELOLABIAL ADVANCED FLAP AND UNDERMINING SURGERY AS OPTIMAL THERAPEUTIC APPROACH. Tchernev G Georgian Med News; 2023 Nov; (344):196-199. PubMed ID: 38236123 [TBL] [Abstract][Full Text] [Related]
32. Nitrosamine Impurities in Herbal Formulations: A Review of Risks and Mitigation Strategies. Shekhar NR; Nagappan K; Singh MT; Dhanabal SP Drug Res (Stuttg); 2023 Oct; 73(8):431-440. PubMed ID: 37487523 [TBL] [Abstract][Full Text] [Related]
33. Regulatory Updates and Analytical Methodologies for Nitrosamine Impurities Detection in Sartans, Ranitidine, Nizatidine, and Metformin along with Sample Preparation Techniques. Shaik KM; Sarmah B; Wadekar GS; Kumar P Crit Rev Anal Chem; 2022; 52(1):53-71. PubMed ID: 32691615 [TBL] [Abstract][Full Text] [Related]
34. Practical and Science-Based Strategy for Establishing Acceptable Intakes for Drug Product Dobo KL; Kenyon MO; Dirat O; Engel M; Fleetwood A; Martin M; Mattano S; Musso A; McWilliams JC; Papanikolaou A; Parris P; Whritenour J; Yu S; Kalgutkar AS Chem Res Toxicol; 2022 Mar; 35(3):475-489. PubMed ID: 35212515 [TBL] [Abstract][Full Text] [Related]
35. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study. MacFadyen RJ; Lees KR; Reid JL Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084 [TBL] [Abstract][Full Text] [Related]
36. Clinical acceptability of ACE inhibitor therapy in mild to moderate hypertension, a comparison between perindopril and enalapril. Alcocer L; Campos C; Bahena JH; Nacaud A; Parra Carillo J; Calvo C; Weber C; Lerebours G; Mickalonis L; Villahermosa MT Cardiovasc Drugs Ther; 1995 Jun; 9(3):431-6. PubMed ID: 8527353 [TBL] [Abstract][Full Text] [Related]
37. Evaluation and optimization of a HS-SPME-assisted GC-MS/MS method for monitoring nitrosamine impurities in diverse pharmaceuticals. Chang SH; Ho HY; Chang CC; Zang CZ; Hsu YH; Lin MC; Tseng SH; Wang DY J Pharm Biomed Anal; 2022 Nov; 221():115003. PubMed ID: 36095885 [TBL] [Abstract][Full Text] [Related]
38. The EU Response to the Presence of Nitrosamine Impurities in Medicines. Ruepp R; Frötschl R; Bream R; Filancia M; Girard T; Spinei A; Weise M; Whomsley R Front Med (Lausanne); 2021; 8():782536. PubMed ID: 34869504 [TBL] [Abstract][Full Text] [Related]
39. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group. Vítovec J; Spinar J Eur J Heart Fail; 2000 Sep; 2(3):299-304. PubMed ID: 10938492 [TBL] [Abstract][Full Text] [Related]
40. KARAPANDZIC FLAP FOR SQUAMOUS CELL CARCINOMA OF THE LOWER LIPP: POTENTIAL ROLE OF NITROSAMINES IN EPROSARTAN AS CANCER TRIGGERING FACTORS. Tchernev G; Lozev I; Pidakev I; Kordeva S Georgian Med News; 2023 Jan; (334):83-85. PubMed ID: 36864798 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]